Wegovy (semaglutide) is a GLP-1 receptor agonist licensed in the UK for weight management in adults with obesity or overweight with weight-related comorbidities
n thi im ny cha c danh sch y tng nc c cng b rng ri, v vy s lng quc gia chnh xc lu hnh thng mi c th tip tc thay i theo tng t cp nht mi
However, because glucagon-like peptide-1 receptor agonists work to slow gastric emptying, a safety concern has been raised in patients undergoing deep sedation or general anesthesia regarding gastric aspiration, and considering their long half-life in the blood, they are difficult to manage in the perioperative period
112,120,121,122,123 Notably, a meta-analysis (n = 399 HAPE/495 controls) confirmed the significance of the rs1799983 polymorphism in increasing HAPE risk among Asians
Every morning, I wake up, I tell myself I have an eating disorder